학술논문

Empagliflozin attenuates intestinal inflammation through suppression of nitric oxide synthesis and myeloperoxidase activity in in vitro and in vivo models of colitis
Document Type
Journal
Source
INFLAMMOPHARMACOLOGY; APR 22 2023, 16p.
Subject
Language
English
ISSN
15685608